DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Tefibazumab
Tefibazumab
WO 2015/028850 Al 5 March 2015 (05.03.2015) P O P C T
Modifications to the Harmonized Tariff Schedule of the United States To
Advice Concerning the Addition of Certain Pharmaceutical Products
(INN) for Biological and Biotechnological Substances
Monoclonal Antibodies As an Antibacterial Approach Against Bacterial Pathogens
Stembook 2018.Pdf
(INN) for Biological and Biotechnological Substances
(12) United States Patent (10) Patent No.: US 9,446,134 B2 Maggio (45) Date of Patent: *Sep
A61K9/51 (2006.01) — with International Search Report (Art
Who Expert Committee on Specifications for Pharmaceutical Preparations
Preclinical Efficacy of Clumping Factor a in Prevention of Staphylococcus Aureus Infection
WO 2014/093640 Al 19 June 2014 (19.06.2014) P O P C T
Staphylococcus Aureus Clumping Factor a Is a Force-Sensitive Molecular Switch That Activates Bacterial Adhesion
History and Practice: Antibodies in Infectious Diseases ADAM HEY1 1Preclinical Safety, Biologics, Novartis AG, Basel, Switzerland
International Nonproprietary Names for Biological and Biotechnological Substances: a Review17
Self-Study Report Department of Biochemistry and Biophysics External Academic Program Review, April 2021
T Cell Immunity and the Quest for Protective Vaccines Against Staphylococcus Aureus Infection
Manuscript for Human Monoclonal Antibodies Against
Top View
The Use of Antibodies in the Treatment of Infectious Diseases Chan C E Z, Chan a H Y, Hanson B J, Ooi E E
Customs Tariff - Schedule Xxi - 1
INN-Nimet 1 27.11.2018 a Abacavir Abacavirum Abakaviiri Abagovomab
Vaccine Monoclonal Antibody-Based Therapies for Microbial Diseases
Antibody-Based Therapy to Combat Staphylococcus Aureus Infections
Staphylococcus Aureus Colonization and Infection by B- and T-Cell-Mediated Mechanisms
Characterization and Identification of Novel Biofilm Forming Antigens of Staphylococcus Aureus of Human Origin
(12) United States Patent (10) Patent No.: US 9,701,738 B2 Mcadow Et Al
Mechanostability of the Fibrinogen Bridge Between Staphylococcal
Vaccines to Prevent Antibiotic Resistant Staphylococcus Aureus (MRSA)
A Scientific Roadmap for Antibiotic Discovery
(INN) for Biological and Biotechnological Substances
Exebacase for Staphylococcus Aureus Bloodstream Infection and Endocarditis
WO 2013/162751 Al 31 October 2013 (31.10.2013) P O P C T
The Search for an Effective Staphylococcus Aureus Vaccine
Assessment of the Evolution of Cancer Treatment Therapies
Targeted Therapeutic Strategies in the Battle Against Pathogenic Bacteria
Monoclonal Antibodies Targeting Surface-Exposed and Secreted Proteins from Staphylococci